Literature DB >> 15166275

Leukaemia/lymphoma cell microparticles in childhood mature B cell neoplasms.

S Savaşan1, M Büyükavci, S Buck, Y Ravindranath.   

Abstract

AIMS: Because of the observation of an abundance of leukaemia/lymphoma cell microparticles in the bone marrow aspiration sample of a patient with Burkitt's leukaemia at diagnosis, the occurrence of this phenomenon in leukaemia/lymphoma samples with available immune phenotyping data was investigated retrospectively.
METHODS: Flow cytometric immune phenotyping and spontaneous apoptosis analysis of the bone marrow mononuclear cell preparation of the index case were performed. Microparticles isolated form the bone marrow sample were also studied for the presence of leukaemia/lymphoma cell microparticles. List mode analysis of 225 cases of acute leukaemia or lymphoma with previously performed immune phenotyping was also carried out.
RESULTS: The presence of leukaemia/lymphoma cell microparticles could be detected by flow cytometry and they were found to be different from apoptotic bodies. Leukaemia/lymphoma cell microparticles were released in all cases of mature B cell neoplasms studied, although this phenomenon was rare in precursor B cell disorders and acute myeloid leukaemia.
CONCLUSIONS: The generation of leukaemia/lymphoma cell microparticles in mature B cell neoplasms appears to be a common phenomenon. The pathogenesis and clinical implications must be investigated.

Entities:  

Mesh:

Year:  2004        PMID: 15166275      PMCID: PMC1770322          DOI: 10.1136/jcp.2003.011643

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

Review 1.  General principles of multiparameter flow cytometric analysis: applications of flow cytometry in the diagnostic pathology laboratory.

Authors:  C L Willman; C C Stewart
Journal:  Semin Diagn Pathol       Date:  1989-02       Impact factor: 3.464

2.  Multidimensional flow cytometric blood cell differentiation without erythrocyte lysis.

Authors:  L W Terstappen; D Johnson; R A Mickaels; J Chen; G Olds; J T Hawkins; M R Loken; J Levin
Journal:  Blood Cells       Date:  1991

3.  Production of platelet-like particles by a human megakaryoblastic leukemia cell line (MEG-01).

Authors:  K Takeuchi; M Ogura; H Saito; M Satoh; M Takeuchi
Journal:  Exp Cell Res       Date:  1991-03       Impact factor: 3.905

4.  Functional gene transfer of HIV DNA by an HIV receptor-independent mechanism.

Authors:  A L Spetz; B K Patterson; K Lore; J Andersson; L Holmgren
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

5.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.

Authors:  V Combes; A C Simon; G E Grau; D Arnoux; L Camoin; F Sabatier; M Mutin; M Sanmarco; J Sampol; F Dignat-George
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

6.  Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease.

Authors:  J J Jimenez; W Jy; L M Mauro; L L Horstman; Y S Ahn
Journal:  Br J Haematol       Date:  2001-01       Impact factor: 6.998

7.  Comparison of DiOC(6)(3) uptake and annexin V labeling for quantification of apoptosis in leukemia cells and non-malignant T lymphocytes from children.

Authors:  U Ozgen; S Savaşan; S Buck; Y Ravindranath
Journal:  Cytometry       Date:  2000-02-15
  7 in total
  2 in total

1.  Exclusion of cytoplasmic fragments in flow cytometric analysis of lymph node samples from dogs with lymphoma using membrane-permeable violet laser-excitable DNA-binding fluorescent dye (DyeCycle Violet).

Authors:  Daisuke Ito; Timothy D O'Brien; Jaime F Modiano
Journal:  Vet Clin Pathol       Date:  2010-09-21       Impact factor: 1.180

Review 2.  Membrane microparticles: shedding new light into cancer cell communication.

Authors:  Paloma Silva de Souza; Roberta Soares Faccion; Paula Sabbo Bernardo; Raquel Ciuvalschi Maia
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-19       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.